|
HS Code |
794439 |
| Chemicalname | 1-(Bromomethyl)-4-Phenoxybenzene |
| Molecularformula | C13H11BrO |
| Molecularweight | 263.13 g/mol |
| Casnumber | 83453-87-8 |
| Appearance | White to off-white solid |
| Boilingpoint | 359.5°C at 760 mmHg |
| Density | 1.42 g/cm³ |
| Purity | Typically ≥98% |
| Solubility | Insoluble in water; soluble in organic solvents such as DMSO and ethanol |
| Smiles | C1=CC(=CC=C1CO)OC2=CC=CC=C2Br |
| Inchi | InChI=1S/C13H11BrO/c14-10-11-5-7-13(8-6-11)15-12-3-1-2-4-9-12/h1-9H,10H2 |
As an accredited 1-(Bromomethyl)-4-Phenoxybenzene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 1-(Bromomethyl)-4-Phenoxybenzene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Walk into any chemistry lab working at the cutting edge of pharmaceutical, agrochemical, or fine chemicals research and you might hear people talking about more than the classic reagents. Newer intermediates have taken center stage, and those with a strong background in organic chemistry know that subtle differences in structure often make the biggest impact on performance and route selection. In this landscape, 1-(Bromomethyl)-4-Phenoxybenzene stands out as a nimble, effective intermediate that experts often look for when mapping multi-step synthetic strategies.
Chemists tend to look past the mouthful of a name and see reactivity, utility, and synthesis opportunity. Take 1-(Bromomethyl)-4-Phenoxybenzene. It brings together the benzyl bromide motif, known for its ability to participate in versatile substitution reactions, with a phenoxy substituent that can alter electronic and steric environments in predictable, useful ways. It’s this pairing that makes the molecule interesting in the lab. Compare this to simpler benzyl bromide or basic phenoxybenzene: alone, each offers something, but rarely the tailored reactivity required for controlled transformations that crop up in new technology spaces.
A small, white crystalline powder at pure concentrations, 1-(Bromomethyl)-4-Phenoxybenzene carries the CAS number 41661-48-7 for those cataloging or cross-referencing. Physical purity here isn’t just a bragging point — it affects reaction reliability and downstream purification. In controlled conditions, its stability means it stores well and keeps its performance profile, avoiding problems associated with more volatile or sensitive analogs.
Ask anyone with hands-on experience in mid- to late-stage synthesis: reactivity control matters most. Using 1-(Bromomethyl)-4-Phenoxybenzene lets chemists introduce functional groups exactly where they want. The benzylic bromide group activates the molecule toward SN2 and related pathways, unlike less activated arenes. Imagine scaling up for an early drug candidate — time and yield count. This compound’s structure helps improve both, offering predictable performance for ether bond formation, Suzuki or Buchwald-type cross-couplings, or as a building block in synthesizing larger, more complex molecules where ortho- and para-substitution patterns must match exacting blueprints.
In a pharmaceutical research context, chemists sometimes need to append a phenoxy group to a benzyl position, using the bromine as a leaving group. Direct phenolation, in many cases, comes with unwanted by-products, rearrangements, or low selectivity. Using a ready-made 1-(Bromomethyl)-4-Phenoxybenzene saves time and bypasses tedious purification steps. Colleagues aiming for a specific ligand scaffold or aromatic backbone rely on this kind of shortcut, keeping resources focused on later stages where more customization comes into play.
Looking further afield, crop science and industrial polymers sometimes put this molecule to work as a coupling partner for aromatic ether linkages. In these sectors, reliability of supply and well-characterized reactivity ensure process consistency at scale — a must for any commercial launch where lots run into hundreds of kilograms. Other products, such as simple benzyl bromide derivatives, bring more off-target reactivity or produce more side products, adding downstream work and increasing costs. Skipping those headaches means more reliable delivery of standards that stakeholders and regulators track.
Plenty of bromomethylated aromatics jostle for space on lab shelves. Comparing the performance of 1-(Bromomethyl)-4-Phenoxybenzene with these isn’t just a matter of price per gram or ease of shipping. Skill lies in choosing the right reactivity for the stage at hand. Standard benzyl bromide is potent, but chemoselectivity often suffers when multiple nucleophiles or functional groups are present. Side reactions — alkylation at unintended sites, overalkylation, even rearrangements — frequently frustrate the process chemist under tight deadlines.
With a phenoxy substituent at the para position, the electronic character of the benzylic carbon shifts. Nucleophilic aromatic substitution proceeds more cleanly, and the leaving group leaves without pulling in excess electron density from neighboring groups. Chemists find that, for work on aromatic scaffolds where selective reactivity is the difference between success and wasted effort, this difference saves time and money. Colleagues report fewer side products compared to simple benzyl bromide or other asymmetrical bromomethyl benzenes. This means easier purification — less chasing by-products through column chromatography — and higher yields at each step.
Another advantage comes in work-up and environmental footprint. Standard alkyl bromides, while reactive, often demand extra post-reaction treatments to handle excess bromine or stabilize more volatile intermediates. Here, handling is easier, and waste management routines avoid some headaches associated with more aggressive alternatives. Drawing from real lab experience, avoiding extra purification cycles means more than saved time; it lowers overall chemical waste and matches goals set by many groups to promote greener, more sustainable chemistry.
Seasoned researchers don’t take raw material quality for granted. Whether working in academia or the chemical industry, deep experience teaches that trace impurities linger, often waiting to sabotage key steps at unpredictable moments. In the digital age, quality isn’t just about the number on a label — it’s demonstrated through batch consistency, transparency in handling, and an open record of compliance. These principles, reflected in Google’s E-E-A-T framework — expertise, experience, authoritativeness, trustworthiness — align well with chemical supply practices when done right. Sourcing 1-(Bromomethyl)-4-Phenoxybenzene from a supplier who provides full background data, certificates, and robust batch histories gives researchers confidence to stake a campaign’s success on its use.
Training new chemists, I always emphasized the value of reading not just the chemical’s name, but its background. A batch full of trace by-products poses a risk when synthesizing sensitive molecules. A few parts per thousand of another halide, residual solvent, or unreacted starting material can cascade into headaches at scale-up. This awareness comes from years at the bench — there’s no substitute for building trust with materials and the people supplying them.
New synthetic methods spring up every year, but bottlenecks persist. In my experience, challenges often appear at steps where functionalization must be selective, scalable, and compatible with protecting group strategies. 1-(Bromomethyl)-4-Phenoxybenzene earned its spot in reagent rotations because, for many substitution, alkylation, or arylation operations, it brings together a fine balance: strong enough to push forward, controlled enough to avoid costly detours. Replacing riskier reagents with selective alternatives saves both time and safety effort — an undeniable win for all lab staff.
Pharmaceutical pipeline teams point to increasing scrutiny on process waste and environmental impact. Choosing cleaner intermediates at early stages shapes the sustainability profile of a project all the way through to launch. Minimizing halogenated waste early helps reduce the need for elaborate decontamination steps. Rather than chasing higher yields through brute force, smart selection of building blocks — including 1-(Bromomethyl)-4-Phenoxybenzene — sets a project on the right track for regulatory review and for crossing the finish line in manufacturing scale-up.
In my teaching days, I challenged students to think several steps ahead in a synthetic sequence. Choosing the right intermediate lets later protections, deprotections, or functional group exchanges proceed with less risk. The stability of this compound, its predictable reactivity, and a track record in diverse settings give a serious edge. Synthetic chemists know that avoiding unplanned troubleshooting means hitting timelines and milestones, not burning up nights in the lab chasing side reactions. Here, process know-how meets chemical insight, with a visible return on investment measured in both time and stress.
Seasoned process chemists, especially those managing larger teams, value feedback loops from the shop floor or kilo lab. Reports trickle in about lower-than-expected by-product profiles, shorter purification workflows, and smoother transitions from bench to pilot plant using this intermediate, compared to direct benzyl bromide analogs. At conferences, conversations often center on how these subtle molecular differences resolve recurring problems with older, less specialized reagents. It’s not just academic — every hour saved downstream supports overall project momentum.
Many large-volume users prioritize proven track records. They want intermediates that keep their compliance files clean and manufacturing lines moving. 1-(Bromomethyl)-4-Phenoxybenzene, when sourced from thoroughly vetted suppliers, consistently delivers batches with high assay values and low levels of trace contaminants. Pattern recognition from repeated successes leads to standardization; this intermediate forms the backbone of proprietary synthesis steps in APIs, agricultural actives, and specialty material monomers that must meet strict quality standards set by regulators around the globe.
Over years of troubleshooting, chemists contacted colleagues, searched literature, and ran control experiments, looking for bottleneck solutions. Few changes deliver as much sustained benefit as swapping out less selective reagents for those that match modern synthetic requirements. Choosing more controlled intermediates often resolves repeat failures or messy extractions — an investment that pays dividends each campaign.
Peer-reviewed studies, process validation records, and scale-up reports give hard numbers to back up field impressions. Using 1-(Bromomethyl)-4-Phenoxybenzene in key functionalization steps, researchers have documented yield uplift by several percentage points over related bromomethylated aromatics. Lower impurity spikes keep analytical teams on track, and tighter reproducibility supports regulatory filings in both the United States and Europe. Importantly, waste stream analysis frequently shows reductions in problematic halogenated by-products, a win for environmental performance reporting and plant safety audits.
In settings where the final active ingredient must clear strict threshold limits for trace halogens, improvements like these matter. Analytical teams chase down every peak on the chromatogram, and lower off-target reactivity simplifies both the analysis and the back-end paperwork. Having a robust, well-characterized intermediate upstream pays off when mounting the final product defense before a regulatory agency.
The chemical marketplace evolves fast. Synthetic methodologies keep pushing the envelope — exploring greener routes, bioorthogonal steps, and complex, multifunctional end products. Adaptable intermediates like 1-(Bromomethyl)-4-Phenoxybenzene play key roles as platforms. Their stable yet reactive character matches well with both emerging and established technologies, from automated flow synthesis to catalyst-driven asymmetric transformations.
Teams working in drug discovery or material science increasingly adopt flexible building blocks to keep late-stage programs agile. Rather than rebuilding synthetic routes from scratch with every new target, using intermediates with proven utility speeds up route scouting and optimization. This compound’s performance history and wide reactivity spectrum position it as a go-to choice for seasoned chemists who want to match new methodological breakthroughs with tried-and-tested materials.
Regulatory bodies, sponsors, and investors now focus as much on provenance and sustainability as raw performance metrics. Sourcing intermediates from transparent, responsible suppliers aligns with broader best practices. Experts who have worked through regulatory filings or environmental audits see value in intermediates that tick all boxes — chemical performance, robust quality data, and a minimal environmental footprint. In the long run, the right selection supports not just successful syntheses but also strong reputations and trusted collaborations.
Choosing a supply partner for key intermediates reflects an organization’s dedication to quality and reliability. Relying on suppliers who provide batch histories, certificates of analysis, and transparent compliance documentation means fewer surprises in the lab and at scale-up. Experienced chemists trade tips on which vendors deliver on time, maintain robust environmental, health and safety standards, and respond promptly to technical requests. In highly regulated industries, this due diligence is not optional — it’s mission-critical.
Once on-site, best practice includes keeping materials in dry, stable conditions and integrating them into electronic inventory systems that link batch data with each reaction step. Regular review of incoming and outgoing material use, along with ongoing training on best handling practices, supports continuous improvement at every stage — from lab bench to full commercial batches. Institutions with solid track records often maintain formal feedback cycles, adjusting procurement and handling based on lessons learned in each campaign.
In my own experience leading multi-step synthesis projects, I found that early alignment with suppliers, analytical departments, and process chemists smoothed over many headaches before they started. Adopting 1-(Bromomethyl)-4-Phenoxybenzene as a standard building block brought tangible returns: more predictable synthesis, faster troubleshooting, and lower risk all around. Sharing real world case studies and outcome data encourages broader adoption and drives overall quality upward across the industry.
Each decision made at the planning stage of a synthesis shapes everything that follows. 1-(Bromomethyl)-4-Phenoxybenzene may not command headlines outside specialist circles, yet its quiet reliability and adaptability make a real impact. Chemists seeking to streamline functionalization steps, control by-products, and safeguard both environmental and business bottom lines consistently find it an ally worth relying on. Real experience and credible data support its growing role — not just as an option on a reagent list, but as a pivot point for building smarter, cleaner synthetic routes.
Choosing the right intermediate unlocks flexibility and supports both short-term wins and long-term sustainability. For teams gearing up for new product launches, regulatory filings, or process improvement campaigns, it makes sense to put time and care into each sourcing decision. As chemistry pushes toward increasingly rigorous standards and bolder goals, intermediates like 1-(Bromomethyl)-4-Phenoxybenzene, backed by evidence, expertise, and clear communication, provide the foundation for progress that endures.